Skip to content
October 25, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Merck KGaA Signals New Era with $11.3bn Acquisition of Bio-Techne merck-kgaa-signals-new-era-with-11-3bn-acquisition-of-bio-techne
  • Treatment Innovations

Merck KGaA Signals New Era with $11.3bn Acquisition of Bio-Techne

Layla Zulfa June 27, 2026
In a move that underscores a shifting landscape within the global pharmaceutical and life sciences sector, German...
Read More Read more about Merck KGaA Signals New Era with $11.3bn Acquisition of Bio-Techne
Regulatory Shake-up: Acadia’s Daybue Wins EU Support as Amgen’s Tavneos Faces Withdrawal regulatory-shake-up-acadias-daybue-wins-eu-support-as-amgens-tavneos-faces-withdrawal
  • Treatment Innovations

Regulatory Shake-up: Acadia’s Daybue Wins EU Support as Amgen’s Tavneos Faces Withdrawal

Lina Hope June 27, 2026
By Jonathan Gardner | June 26, 2026 In a landmark decision that promises to reshape the treatment...
Read More Read more about Regulatory Shake-up: Acadia’s Daybue Wins EU Support as Amgen’s Tavneos Faces Withdrawal
Alkermes’ Strategic Pivot: Betting the Future on Orexin Agonism alkermes-strategic-pivot-betting-the-future-on-orexin-agonism
  • Chemotherapy and Targeted Therapy

Alkermes’ Strategic Pivot: Betting the Future on Orexin Agonism

Sagoh June 27, 2026
In a transformative period that has sent shockwaves through the biopharmaceutical sector, Dublin-based Alkermes has emerged as...
Read More Read more about Alkermes’ Strategic Pivot: Betting the Future on Orexin Agonism
The Shifting Landscape of Medicaid and CHIP: A Decade of Enrollment Volatility the-shifting-landscape-of-medicaid-and-chip-a-decade-of-enrollment-volatility
  • Breast Cancer Legislation and Policy

The Shifting Landscape of Medicaid and CHIP: A Decade of Enrollment Volatility

Laily UPN June 27, 2026
The landscape of American public health coverage is undergoing its most significant transformation since the inception of...
Read More Read more about The Shifting Landscape of Medicaid and CHIP: A Decade of Enrollment Volatility
The Quiet Revolution: Why ‘Legs Up the Wall’ Is the Essential Antidote to Modern Burnout the-quiet-revolution-why-legs-up-the-wall-is-the-essential-antidote-to-modern-burnout
  • Integrative Oncology and Holistic Care

The Quiet Revolution: Why ‘Legs Up the Wall’ Is the Essential Antidote to Modern Burnout

Nana Muazin June 27, 2026
In an era defined by relentless connectivity and the "hustle culture" that dominates modern urban life, the...
Read More Read more about The Quiet Revolution: Why ‘Legs Up the Wall’ Is the Essential Antidote to Modern Burnout
Unmasking a Master Switch: Decades-Old Protein EPO Revealed as Potent Immune Suppressor in Cancer unmasking-a-master-switch-decades-old-protein-epo-revealed-as-potent-immune-suppressor-in-cancer
  • Medical Research and Clinical Trials

Unmasking a Master Switch: Decades-Old Protein EPO Revealed as Potent Immune Suppressor in Cancer

Suro Senen June 27, 2026
STANFORD, CA – April 24, 2024 – In a discovery poised to revolutionize cancer immunotherapy, scientists have...
Read More Read more about Unmasking a Master Switch: Decades-Old Protein EPO Revealed as Potent Immune Suppressor in Cancer
The FDA’s Commissioner’s National Priority Voucher: A Paradigm Shift in Regulatory Speed or a Blueprint for Institutional Chaos? the-fdas-commissioners-national-priority-voucher-a-paradigm-shift-in-regulatory-speed-or-a-blueprint-for-institutional-chaos
  • Treatment Innovations

The FDA’s Commissioner’s National Priority Voucher: A Paradigm Shift in Regulatory Speed or a Blueprint for Institutional Chaos?

Reynand Wu June 27, 2026
Since its inception in June 2025, the U.S. Food and Drug Administration’s (FDA) Commissioner’s National Priority Voucher...
Read More Read more about The FDA’s Commissioner’s National Priority Voucher: A Paradigm Shift in Regulatory Speed or a Blueprint for Institutional Chaos?
Johnson & Johnson Launches Landmark SKYWARD Programme to Tackle Calcified Carotid Artery Disease johnson-johnson-launches-landmark-skyward-programme-to-tackle-calcified-carotid-artery-disease
  • Treatment Innovations

Johnson & Johnson Launches Landmark SKYWARD Programme to Tackle Calcified Carotid Artery Disease

Nana Muazin June 27, 2026
In a significant move to advance endovascular interventions, Johnson & Johnson (J&J) has officially commenced enrolment for...
Read More Read more about Johnson & Johnson Launches Landmark SKYWARD Programme to Tackle Calcified Carotid Artery Disease
Redefining the Standard of Care: How the DAPHNe Trial is Paving the Way for De-escalated Chemotherapy in HER2-Positive Breast Cancer redefining-the-standard-of-care-how-the-daphne-trial-is-paving-the-way-for-de-escalated-chemotherapy-in-her2-positive-breast-cancer
  • Patient Advocacy and Support

Redefining the Standard of Care: How the DAPHNe Trial is Paving the Way for De-escalated Chemotherapy in HER2-Positive Breast Cancer

Nana Wu June 27, 2026
The landscape of oncology is undergoing a seismic shift. For decades, the primary objective of cancer treatment...
Read More Read more about Redefining the Standard of Care: How the DAPHNe Trial is Paving the Way for De-escalated Chemotherapy in HER2-Positive Breast Cancer
The Great Biotech Decoupling: U.S.-China Licensing Frenzy Faces Regulatory Reckoning the-great-biotech-decoupling-u-s-china-licensing-frenzy-faces-regulatory-reckoning
  • Treatment Innovations

The Great Biotech Decoupling: U.S.-China Licensing Frenzy Faces Regulatory Reckoning

Laily UPN June 27, 2026
The landscape of global pharmaceutical innovation is undergoing a profound and potentially destabilizing transformation. As U.S. biotechnology...
Read More Read more about The Great Biotech Decoupling: U.S.-China Licensing Frenzy Faces Regulatory Reckoning

Posts pagination

Previous 1 … 588 589 590 591 592 593 594 … 820 Next

Recent Posts

  • Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Education in the NHS
  • Decoding the Architecture of Addiction: How Model Organisms are Revolutionizing Genetic Research
  • Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem
  • Navigating the Post-Treatment Horizon: Breast Cancer Canada Launches Essential Wellness Webinar Series
  • Navigating the Shift: The Future of Work Requirements in SNAP and Medicaid

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

Gene therapy abstract concept vector illustration.
  • Genomics and Precision Medicine

Bridging the Genomic Gap: How GeNotes is Revolutionizing Clinical Education in the NHS

Nila Kartika Wati October 25, 2026
decoding-the-architecture-of-addiction-how-model-organisms-are-revolutionizing-genetic-research
  • Genomics and Precision Medicine

Decoding the Architecture of Addiction: How Model Organisms are Revolutionizing Genetic Research

Suro Senen October 25, 2026
fueling-the-future-hudsonalpha-launches-the-primer-lab-to-supercharge-alabamas-biotech-ecosystem-8
  • Genomics and Precision Medicine

Fueling the Future: HudsonAlpha Launches ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Nana Wu October 25, 2026
navigating-the-post-treatment-horizon-breast-cancer-canada-launches-essential-wellness-webinar-series
  • Psychosocial Support and Mental Health

Navigating the Post-Treatment Horizon: Breast Cancer Canada Launches Essential Wellness Webinar Series

Dwi Wanna October 25, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.